SCHEMBL508967

SCHEMBL508967

CCc1cc(CC)c(CO)c(CC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPA5 P11021 1/20 0.39
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
DHFR P00374 2/20 0.37
KDM4E B2RXH2 2/20 0.35
CASP6 P55212 1/20 0.35
BACE1 P56817 1/20 0.35
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
MAPT P10636 1/20 0.35
TRPA1 O75762 1/20 0.34
SHBG P04278 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PTGS2 P35354 1/20 0.33
PKM P14618 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14304473 0.90 HSPA5 (0.39) HSPA5MEN1GAAKMT2ADHFR
SCHEMBL1760666 0.81 DHFR (0.44) HSPA5MEN1GAAKMT2ADHFR
SCHEMBL508950 0.80 ALDH1A1 (0.38) HSPA5GAAKMT2AKDM4EALDH1A1
SCHEMBL18242007 0.77 HSPA5 (0.36) HSPA5MEN1GAAKMT2ADHFR
SCHEMBL992788 0.76 TRPA1 (0.46) HSPA5MEN1GAAKMT2ADHFR
SCHEMBL14301045 0.75 TRPA1 (0.50) HSPA5GAAKDM4EBACE1MAPT
SCHEMBL509610 0.75 HSPA5 (0.35) HSPA5MEN1GAAKMT2ADHFR
SCHEMBL18378504 0.75 HSPA5 (0.35) HSPA5MEN1GAAKMT2ADHFR
SCHEMBL509442 0.75 HSPA5 (0.35) HSPA5MEN1GAAKMT2ADHFR
SCHEMBL2221247 0.75 SHBG (0.54) HSPA5MEN1GAAKMT2ADHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116813666-A Phosphine ligand compound with benzyl alcohol group and preparation method and application thereof 中国石油化工股份有限公司 2023-09-29 CN disclosed
CN-116813451-A Substituted benzyl alcohol compound and preparation method and application thereof 中国石油化工股份有限公司 2023-09-29 CN disclosed
EP-2334175-B1 PHENYL-SUBSTITUTED BICYCLOOCTANE 1,3 DIONE DERIVATIVES BAYER IP GMBH (DE) 2017-03-01 EP disclosed
US-8507410-B2 Pyridazinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-08-13 US disclosed
CN-102421759-A Pyridazinone compounds and use thereof SUMITOMO CHEMICAL CO 2012-04-18 CN disclosed
US-20120028803-A1 PYRIDAZINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028803-A1 PYRIDAZINONE COMPOUND AND USE THEREOF C5, C1S, WEE1 HSPA5 2446/4885MEN1 806/4885GAA 4766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.